DrugInformer Search


Ingredients: Amlodipine Maleate
Average User Review Score
* Based on 0 reviews from across the web.

Amlodipine (as besylate, mesylate or maleate) is a medication used to lower blood pressure and prevent chest pain. It belongs to a group of medications known as dihydropyridine-type calcium channel blockers. By widening of blood vessels it lowers blood pressure. In angina, amlodipine increases blood flow to the heart muscle to relieve pain due to angina.

Read more on Wikipedia

  Please use Workbench for in-depth research on Amvaz.

Common adverse events from online conversations
Common adverse events from FDA database
* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Amvaz

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: None

Posted By Anonymous in facebook.com on March 21, 2010 @ 12:00 am

Cindy Amlodis; Amvaz; Coroval; Lipinox; Lotrel; Norvasc; Absorption: Amlodipine is slowly and almost completely absorbed from the gastrointestinal tract. Toxicity (Overdose): Gross overdosage could re...

Druginformer Identified Side Effects: None

Posted By Anonymous in facebook.com on March 21, 2010 @ 12:00 am

Cindy Drug InfoNet - Norvasc - [heart] Drug InfoNet is your one-stop WWW site for all your healthcare informational needs. We provide both information and links to areas on the web concerning ...

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.